{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:32:31Z","timestamp":1786789951268,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,24]],"date-time":"2010-04-24T00:00:00Z","timestamp":1272067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s11894-010-0104-5","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T11:33:52Z","timestamp":1272022432000},"page":"195-202","source":"Crossref","is-referenced-by-count":31,"title":["Sclerosing Cholangitis: Pediatric Perspective"],"prefix":"10.1007","volume":"12","author":[{"given":"Nanda","family":"Kerkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Miloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,24]]},"reference":[{"key":"104_CR1","volume-title":"Liver Disease in Childhood","year":"2007","unstructured":"Suchy FJ, Sokol RJ, Balistreri WF, eds: Liver Disease in Childhood, edn 3. New York: Cambridge University Press; 2007.","edition":"3"},{"key":"104_CR2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/bega.2001.0213","volume":"15","author":"G Mieli-Vergani","year":"2001","unstructured":"Mieli-Vergani G, Vergani D: Sclerosing cholangitis in the paediatric patient. Best Pract Res Clin Gastroenterol 2001, 15:681\u2013690.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"104_CR3","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","volume":"102","author":"GG Kaplan","year":"2007","unstructured":"Kaplan GG, Laupland KB, Butzner D, et al.: The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 2007, 102:1042\u20131049.","journal-title":"Am J Gastroenterol"},{"key":"104_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","volume":"7","author":"T Miloh","year":"2009","unstructured":"\u2022 Miloh T, Arnon R, Shneider B, et al.: A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009, 7:239\u2013245. This single-center study from Mount Sinai Medical Center focuses on demographic, clinical, laboratory, histologic, and endoscopic features of pediatric PSC. It also describes the treatment and outcome of medical interventions and transplant. It reports a subgroup of patients with PSC and positive liver autoimmune markers without histologic evidence of AIH who responded to UDCA alone.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"104_CR5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/bega.2001.0204","volume":"15","author":"E Schrumpf","year":"2001","unstructured":"Schrumpf E, Boberg KM: Epidemiology of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001, 15:553\u2013562.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"104_CR6","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3748\/wjg.v13.i41.5421","volume":"13","author":"TH Karlsen","year":"2007","unstructured":"Karlsen TH, Schrumpf E, Boberg KM: Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol 2007, 13:5421\u20135431.","journal-title":"World J Gastroenterol"},{"key":"104_CR7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","volume":"44","author":"NF LaRusso","year":"2006","unstructured":"LaRusso NF, Shneider BL, Black D, et al.: Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006, 44:746\u2013764.","journal-title":"Hepatology"},{"key":"104_CR8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2008.07.033","volume":"50","author":"L Henckaerts","year":"2009","unstructured":"Henckaerts L, Jaspers M, Van Steenbergen W, et al.: Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis. J Hepatol 2009, 50:150\u2013157.","journal-title":"J Hepatol"},{"key":"104_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","volume":"38","author":"AE Feldstein","year":"2003","unstructured":"Feldstein AE, Perrault J, El-Youssif M, et al.: Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003, 38:210\u2013217.","journal-title":"Hepatology"},{"key":"104_CR10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","volume":"6","author":"A Bergquist","year":"2008","unstructured":"Bergquist A, Montgomery SM, Bahmanyar S, et al.: Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2008, 6:939\u2013943.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"104_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cld.2007.11.012","volume":"12","author":"D Vergani","year":"2008","unstructured":"\u2022 Vergani D, Mieli-Vergani G: Autoimmune hepatitis and PSC connection. Clin Liver Dis 2008, 12:187\u2013202. This article describes the connection between AIH and PSC as immune-mediated diseases lying within the spectrum of the same disease process.","journal-title":"Clin Liver Dis"},{"key":"104_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(87)80072-0","volume":"111","author":"O Amedee-Manesme","year":"1987","unstructured":"Amedee-Manesme O, Bernard O, Brunelle F, et al.: Sclerosing cholangitis with neonatal onset. J Pediatr 1987, 111:225\u2013229.","journal-title":"J Pediatr"},{"issue":"1 Pt 1","key":"104_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","volume":"131","author":"J Levy","year":"1997","unstructured":"Levy J, Espanol-Boren T, Thomas C, et al.: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997, 131(1 Pt 1):47\u201354.","journal-title":"J Pediatr"},{"key":"104_CR14","first-page":"1415","volume":"22","author":"M Wilschanski","year":"1995","unstructured":"Wilschanski M, Chait P, Wade JA, et al.: Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995, 22:1415\u20131422.","journal-title":"Hepatology"},{"key":"104_CR15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J, et al.: Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001, 33:544\u2013553.","journal-title":"Hepatology"},{"key":"104_CR16","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","volume":"100","author":"A Floreani","year":"2005","unstructured":"Floreani A, Rizzotto ER, Ferrara F, et al.: Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005, 100:1516\u20131522.","journal-title":"Am J Gastroenterol"},{"key":"104_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9610(89)90314-0","volume":"158","author":"NS Hadjis","year":"1989","unstructured":"Hadjis NS, Adam A, Blenkharn I, et al.: Primary sclerosing cholangitis associated with liver atrophy. Am J Surg 1989, 158:43\u201347.","journal-title":"Am J Surg"},{"key":"104_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(94)70253-5","volume":"124","author":"D Debray","year":"1994","unstructured":"Debray D, Pariente D, Urvoas E, et al.: Sclerosing cholangitis in children. J Pediatr 1994, 124:49\u201356.","journal-title":"J Pediatr"},{"key":"104_CR19","volume-title":"Pathology of the Liver","year":"2002","unstructured":"MacSween RN, Burt AD, Portmann BC, et al., eds: Pathology of the Liver, edn 4. New York: Churchill Livingstone; 2002.","edition":"4"},{"issue":"Suppl 1","key":"104_CR20","first-page":"43","volume":"13","author":"J Ludwig","year":"1989","unstructured":"Ludwig J: Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989, 13(Suppl 1):43\u201349.","journal-title":"Am J Surg Pathol"},{"key":"104_CR21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"\u2022 Lindor KD, Kowdley KV, Luketic VA, et al.: High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009, 50:808\u2013814. This long-term, randomized, double-blind controlled trial of high-dose UDCA (28\u201330\u00a0mg\/kg\/d) versus placebo in adults with PSC revealed that high-dose UDCA, although associated with biochemical improvement in PSC, was associated with higher rates of serious adverse events and did not improve survival.","journal-title":"Hepatology"},{"key":"104_CR22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1872-034X.2009.00527.x","volume":"39","author":"J Shi","year":"2009","unstructured":"\u2022 Shi J, Li Z, Zeng X, et al.: Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials. Hepatol Res 2009, 39:865\u2013873. This meta-analysis found that UDCA can improve liver biochemistry, with a trend toward improvement in liver histology and cholangiography, but has no effect on survival free of transplantation.","journal-title":"Hepatol Res"},{"key":"104_CR23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","volume":"124","author":"DS Pardi","year":"2003","unstructured":"Pardi DS, Loftus EV Jr, Kremers WK, et al.: Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124:889\u2013893.","journal-title":"Gastroenterology"},{"key":"104_CR24","doi-asserted-by":"crossref","unstructured":"Elfaki DA, Lindor KD: Antibiotics for the treatment of primary sclerosing cholangitis. Am J Ther 2009 (Epub ahead of print).","DOI":"10.1007\/978-1-4020-9644-0_34"},{"key":"104_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","volume":"47","author":"YK Davies","year":"2008","unstructured":"Davies YK, Cox KM, Abdullah BA, et al.: Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr 2008, 47:61\u201367.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"104_CR26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","volume":"53","author":"AR Baluyut","year":"2001","unstructured":"Baluyut AR, Sherman S, Lehman GA, et al.: Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001, 53:308\u2013312.","journal-title":"Gastrointest Endosc"},{"issue":"Suppl 4","key":"104_CR27","first-page":"753A","volume":"50","author":"T Miloh","year":"2009","unstructured":"Miloh T, Anand R, Yin W, et al.: Pediatric liver transplantation for sclerosing cholangitis. Hepatology 2009, 50(Suppl 4):753A.","journal-title":"Hepatology"},{"key":"104_CR28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","volume":"10","author":"RH Wiesner","year":"1989","unstructured":"Wiesner RH, Grambsch PM, Dickson ER, et al.: Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989, 10:430\u2013436.","journal-title":"Hepatology"},{"key":"104_CR29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","volume":"75","author":"WR Kim","year":"2000","unstructured":"Kim WR, Therneau TM, Wiesner RH, et al.: A revised natural history model for primary sclerosing cholangitis. Mayo Clinic Proc 2000, 75:688\u2013694.","journal-title":"Mayo Clinic Proc"},{"key":"104_CR30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.510250501","volume":"25","author":"K Shetty","year":"1997","unstructured":"Shetty K, Rybicki L, Carey WD: The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997, 25:1049\u20131053.","journal-title":"Hepatology"},{"key":"104_CR31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","volume":"38","author":"U Broome","year":"1996","unstructured":"Broome U, Olsson R, Loof L, et al.: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996, 38:610\u2013615.","journal-title":"Gut"},{"key":"104_CR32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","volume":"100","author":"JM Farrant","year":"1991","unstructured":"Farrant JM, Hayllar KM, Wilkinson ML, et al.: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100:1710\u20131717.","journal-title":"Gastroenterology"},{"key":"104_CR33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","volume":"14","author":"E Cholongitas","year":"2008","unstructured":"Cholongitas E, Shusang V, Papatheodoridis GV, et al.: Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008, 14:138\u2013143.","journal-title":"Liver Transpl"},{"key":"104_CR34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","volume":"14","author":"J Alexander","year":"2008","unstructured":"Alexander J, Lord JD, Yeh MM, et al.: Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008, 14:245\u2013251.","journal-title":"Liver Transpl"},{"issue":"5 Pt 1","key":"104_CR35","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","volume":"92","author":"M el-Shabrawi","year":"1987","unstructured":"el-Shabrawi M, Wilkinson ML, Portmann B, et al.: Primary sclerosing cholangitis in childhood. Gastroenterology 1987, 92(5 Pt 1):1226\u20131235.","journal-title":"Gastroenterology"},{"key":"104_CR36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10024-005-0020-0","volume":"8","author":"LA Batres","year":"2005","unstructured":"Batres LA, Russo P, Mathews M, et al.: Primary sclerosing cholangitis in children: a histologic follow-up study. Pediatr Dev Pathol 2005, 8:568\u2013576.","journal-title":"Pediatr Dev Pathol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-010-0104-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0104-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T17:27:52Z","timestamp":1635269272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-010-0104-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,24]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1007\/s11894-010-0104-5","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,24]]}}}